Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities

BJU International

Volumn 95, Issue 7, 2005, Pages 1086-1090

  Byun, Seok Soo ^a   Kim, Soo W ^a   Choi, Hwang ^a   Lee, Chongwook ^a   Lee, Eunsik ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Bladder cancer; Cisplatin resistance; Glutathione; Glutathione S transferase

Indexed keywords

BUTHIONINE SULFOXIMINE; CISPLATIN; ETACRYNIC ACID; GLUTATHIONE; GLUTATHIONE TRANSFERASE; INDOMETACIN;

ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER RESISTANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 18544373672     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05472.x     Document Type: Article

References (29)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36
2. Rubben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G. Natural history and treatment of low and high risk superficial bladder tumors. J Urol 1988; 139: 283-5
3. Steinberg GD, Trump DL, Cummings KB. Metastatic bladder cancer, natural history, clinical course, and consideration for treatment. Urol Clin North Am 1992; 9: 735-46
4. Perry JJ, Muss HB. Management of disseminated disease in the patient with bladder cancer. Urol Clin Nor Am 1994; 21: 661-72
5. Andrews PA, Velury S, Mann SC, Howell SB. cis-Diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 1988; 48: 68-73
6. Kraker AJ, Moore CW. Accumulation of cis-Diamminedichloroplatinum (II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. Cancer Res 1988; 48: 9-13
7. Hospers GA, Meijer C, de Leij J, Uges DRA, Mulder NH, de Vries EGE. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance. Int J Cancer 1990; 46: 138-44
8. Hamilton TC, Winker MA, Louie KG et al. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and - sensitive human ovarian carcinoma cell lines by buthionine sulfoximine-mediated glutathione depletion. Biochem Pharmacol 1985; 34: 2583-6
9. Eastman A, Schute N. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum (II). Biochemistry 1988; 27: 4730-4
10. Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M, Hamilton TC. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res 1988; 48: 5713-6
11. Richon VM, Schute N, Eastman A. Multiple mechanisms of resistance to cis-diamminedichloroplantinum (II) in murine leukemia L1210 cells. Cancer Res 1987; 47: 2056-61
12. Lai GM, Ozols RF, Young RC, Hamilton TC. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J Natl Cancer Inst 1989; 81: 535-9
13. Hong JH, Lee E, Hong J, Shin YJ, Ahn H. Antisense Bcl2 oligonucleotide in cisplatin-resistant bladder cancer cell lines. BJU Int 2002; 90: 113-7
14. Yoon SJ, Park I, Kwak C, Lee E. Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells. Oncol Rep 2003; 10: 1363-7
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54
16. Habig WH, Jakoby WB. Assays for differentiation of glutathione S-transferases. Meth Enzymol 1981; 77: 398-405
17. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47: 936-41
18. Mestdagh N, Pommery N, Saucier JM et al. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes. Anticancer Res 1994; 14: 869-74
19. Yasuno T, Matsumura T, Shikata T et al. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line. Anticancer Res 1999; 19: 4049-57
20. Koga H, Kotoh S, Nakashima M, Yokomizo A, Tanaka M, Naito S. Accumulation of intracellular platinum is correlated with intrinsic cisplatin resistance in human bladder cancer cell lines. Int J Oncol 2000; 16: 1003-7
21. Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE, Cowan KH. Overexpression of a novel anionic glutathione transferase in multidrug resistant breast cancer cells. J Biol Chem 1986; 261: 15544-9
22. Waxman DJ. Glutathione S-transferases. Role in alkylating agent resistance and possible target for modulation chemotherapy - a review. Cancer Res 1990; 50: 6449-54
23. Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 472-7
24. Griffith OW, Meister A. Glutathione. Interorgan translocation, turnover, and metabolism. Proc Natl Acad Sci USA 1979; 76: 5606-10
25. Hromas RA, North JA, Burns CP. Decreased cisplatin uptake by resistant L1210 leukemia cells. Cancer Lett 1987; 36: 197-201
26. Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 1990; 62: 72-7
27. Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B, Ringborg U. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res 1991; 51: 94-8
28. Loscalzo J, Freedman J. Purification and characterization of human platelet glutathione S-transferase. Blood 1986; 67: 1695-9
29. Hall A, Robson CN, Hickson ID, Harris AL, Proctor SJ, Cattan AR. Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line. Cancer Res 1989; 49: 6265-8